These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 26648282

  • 1. Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model.
    Bo H, Gao L, Chen Y, Zhang J, Zhu M.
    Mol Med Rep; 2016 Feb; 13(2):1163-71. PubMed ID: 26648282
    [Abstract] [Full Text] [Related]

  • 2. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells.
    Bo H, Zhang S, Gao L, Chen Y, Zhang J, Chang X, Zhu M.
    BMC Cancer; 2013 Oct 25; 13():496. PubMed ID: 24156409
    [Abstract] [Full Text] [Related]

  • 3. WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer.
    Griesmann H, Ripka S, Pralle M, Ellenrieder V, Baumgart S, Buchholz M, Pilarsky C, Aust D, Gress TM, Michl P.
    Neoplasia; 2013 Jan 25; 15(1):11-22. PubMed ID: 23359789
    [Abstract] [Full Text] [Related]

  • 4. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway.
    Hung TH, Hsu SC, Cheng CY, Choo KB, Tseng CP, Chen TC, Lan YW, Huang TT, Lai HC, Chen CM, Chong KY.
    Oncotarget; 2014 Dec 15; 5(23):12273-90. PubMed ID: 25401518
    [Abstract] [Full Text] [Related]

  • 5. WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer.
    Ripka S, König A, Buchholz M, Wagner M, Sipos B, Klöppel G, Downward J, Gress T, Michl P.
    Carcinogenesis; 2007 Jun 15; 28(6):1178-87. PubMed ID: 17227781
    [Abstract] [Full Text] [Related]

  • 6. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
    Bakker ER, Das AM, Helvensteijn W, Franken PF, Swagemakers S, van der Valk MA, ten Hagen TL, Kuipers EJ, van Veelen W, Smits R.
    Carcinogenesis; 2013 Nov 15; 34(11):2629-38. PubMed ID: 23764752
    [Abstract] [Full Text] [Related]

  • 7. Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively.
    Shojima K, Sato A, Hanaki H, Tsujimoto I, Nakamura M, Hattori K, Sato Y, Dohi K, Hirata M, Yamamoto H, Kikuchi A.
    Sci Rep; 2015 Jan 27; 5():8042. PubMed ID: 25622531
    [Abstract] [Full Text] [Related]

  • 8. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
    Jiang JX, Sun CY, Tian S, Yu C, Chen MY, Zhang H.
    Tumour Biol; 2016 Oct 27; 37(10):13893-13902. PubMed ID: 27485116
    [Abstract] [Full Text] [Related]

  • 9. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.
    Schwartz AL, Malgor R, Dickerson E, Weeraratna AT, Slominski A, Wortsman J, Harii N, Kohn AD, Moon RT, Schwartz FL, Goetz DJ, Kohn LD, McCall KD.
    Clin Cancer Res; 2009 Jun 15; 15(12):4114-22. PubMed ID: 19470740
    [Abstract] [Full Text] [Related]

  • 10. Wnt/β-Catenin and Wnt5a/Ca Pathways Regulate Proliferation and Apoptosis of Keratinocytes in Psoriasis Lesions.
    Zhang Y, Tu C, Zhang D, Zheng Y, Peng Z, Feng Y, Xiao S, Li Z.
    Cell Physiol Biochem; 2015 Jun 15; 36(5):1890-902. PubMed ID: 26202350
    [Abstract] [Full Text] [Related]

  • 11. WNT5A/JNK signaling regulates pancreatic cancer cells migration by Phosphorylating Paxillin.
    Wei W, Li H, Li N, Sun H, Li Q, Shen X.
    Pancreatology; 2013 Jun 15; 13(4):384-92. PubMed ID: 23890137
    [Abstract] [Full Text] [Related]

  • 12. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
    Xu W, Wang Z, Zhang W, Qian K, Li H, Kong D, Li Y, Tang Y.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):613-27. PubMed ID: 25305448
    [Abstract] [Full Text] [Related]

  • 13. WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells.
    Wei W, Sun HH, Li N, Li HY, Li X, Li Q, Shen XH.
    Hepatobiliary Pancreat Dis Int; 2014 Oct 28; 13(5):529-38. PubMed ID: 25308364
    [Abstract] [Full Text] [Related]

  • 14. Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells.
    Yamamoto H, Kitadai Y, Yamamoto H, Oue N, Ohdan H, Yasui W, Kikuchi A.
    Gastroenterology; 2009 Jul 28; 137(1):242-52, 252.e1-6. PubMed ID: 19582886
    [Abstract] [Full Text] [Related]

  • 15. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
    Jin F, Qu X, Fan Q, Wang L, Tang T, Hao Y, Dai K.
    Mol Med Rep; 2013 Nov 28; 8(5):1486-92. PubMed ID: 24064566
    [Abstract] [Full Text] [Related]

  • 16. Pim-3 promotes the growth of human pancreatic cancer in the orthotopic nude mouse model through vascular endothelium growth factor.
    Wang C, Li HY, Liu B, Huang S, Wu L, Li YY.
    J Surg Res; 2013 Dec 28; 185(2):595-604. PubMed ID: 23845873
    [Abstract] [Full Text] [Related]

  • 17. Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.
    Cheng R, Sun B, Liu Z, Zhao X, Qi L, Li Y, Gu Q.
    J Cell Physiol; 2014 Dec 28; 229(12):1908-17. PubMed ID: 24464650
    [Abstract] [Full Text] [Related]

  • 18. SphK1 inhibitor SKI II inhibits the proliferation of human hepatoma HepG2 cells via the Wnt5A/β-catenin signaling pathway.
    Liu H, Zhang CX, Ma Y, He HW, Wang JP, Shao RG.
    Life Sci; 2016 Apr 15; 151():23-29. PubMed ID: 26944438
    [Abstract] [Full Text] [Related]

  • 19. Role of Wnt5a in the proliferation of human glioblastoma cells.
    Yu JM, Jun ES, Jung JS, Suh SY, Han JY, Kim JY, Kim KW, Jung JS.
    Cancer Lett; 2007 Nov 18; 257(2):172-81. PubMed ID: 17709179
    [Abstract] [Full Text] [Related]

  • 20. An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis.
    Hanaki H, Yamamoto H, Sakane H, Matsumoto S, Ohdan H, Sato A, Kikuchi A.
    Mol Cancer Ther; 2012 Feb 18; 11(2):298-307. PubMed ID: 22101459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.